182 related articles for article (PubMed ID: 24833090)
1. Association of promoter methylation of ERα and ERβ with sporadic breast cancer--a study from North India.
Chattopadhyay S; Deo SV; Shukla NK; Husain SA
Tumour Biol; 2014 Aug; 35(8):7911-9. PubMed ID: 24833090
[TBL] [Abstract][Full Text] [Related]
2. Clinical implications of ERβ methylation on sporadic breast cancers in Chinese women.
Zhao L; Yu Z; Li Y; Wen X; Ma W; Wang L; Ren J; Liu C; He M; Bai X; Sun M; Zheng Z; Mi X; Wang E; Olopade OI; Jin F; Wei M
Med Oncol; 2012 Sep; 29(3):1569-75. PubMed ID: 22105146
[TBL] [Abstract][Full Text] [Related]
3. CpG methylation of the ERalpha and ERbeta genes in breast cancer.
Kim SJ; Kim TW; Lee SY; Park SJ; Kim HS; Chung KW; Lee ES; Kang HS
Int J Mol Med; 2004 Aug; 14(2):289-93. PubMed ID: 15254780
[TBL] [Abstract][Full Text] [Related]
4. Potential clinical significance of ERβ ON promoter methylation in sporadic breast cancer.
Božović A; Markićević M; Dimitrijević B; Jovanović Ćupić S; Krajnović M; Lukić S; Mandušić V
Med Oncol; 2013; 30(3):642. PubMed ID: 23794253
[TBL] [Abstract][Full Text] [Related]
5. Silencing of estrogen receptor alpha (ERalpha) gene by promoter hypermethylation is a frequent event in Chinese women with sporadic breast cancer.
Zhao L; Wang L; Jin F; Ma W; Ren J; Wen X; He M; Sun M; Tang H; Wei M
Breast Cancer Res Treat; 2009 Sep; 117(2):253-9. PubMed ID: 18814026
[TBL] [Abstract][Full Text] [Related]
6. Harmful effect of ERβ on BCRP-mediated drug resistance and cell proliferation in ERα/PR-negative breast cancer.
Li W; Jia M; Qin X; Hu J; Zhang X; Zhou G
FEBS J; 2013 Dec; 280(23):6128-40. PubMed ID: 24103091
[TBL] [Abstract][Full Text] [Related]
7. Estrogen receptor-alpha promoter methylation in sporadic basal-like breast cancer of Chinese women.
Jing MX; Mao XY; Li C; Wei J; Liu C; Jin F
Tumour Biol; 2011 Aug; 32(4):713-9. PubMed ID: 21625942
[TBL] [Abstract][Full Text] [Related]
8. [Study of the CpG methylation status of ER alpha gene in estrogen receptor alpha-negative breast cancer cell lines and the role of hydralazine demethylation].
Tang B; Jiang J
Zhonghua Bing Li Xue Za Zhi; 2005 May; 34(5):283-7. PubMed ID: 16181550
[TBL] [Abstract][Full Text] [Related]
9. Quantification of estrogen receptor alpha and beta expression in sporadic breast cancer.
Bièche I; Parfait B; Laurendeau I; Girault I; Vidaud M; Lidereau R
Oncogene; 2001 Dec; 20(56):8109-15. PubMed ID: 11781824
[TBL] [Abstract][Full Text] [Related]
10. Association of poor prognosis subtypes of breast cancer with estrogen receptor alpha methylation in Iranian women.
Izadi P; Mehrdad N; Foruzandeh F; Reza NM
Asian Pac J Cancer Prev; 2012; 13(8):4113-7. PubMed ID: 23098526
[TBL] [Abstract][Full Text] [Related]
11. Indole-3-carbinol selectively uncouples expression and activity of estrogen receptor subtypes in human breast cancer cells.
Sundar SN; Kerekatte V; Equinozio CN; Doan VB; Bjeldanes LF; Firestone GL
Mol Endocrinol; 2006 Dec; 20(12):3070-82. PubMed ID: 16901971
[TBL] [Abstract][Full Text] [Related]
12. Promoter methylation status and expression of estrogen receptor alpha in familial breast cancer patients.
Wei J; Han B; Mao XY; Wei MJ; Yao F; Jin F
Tumour Biol; 2012 Apr; 33(2):413-20. PubMed ID: 21922275
[TBL] [Abstract][Full Text] [Related]
13. Estrogen receptor alpha negative breast cancer patients: estrogen receptor beta as a therapeutic target.
Skliris GP; Leygue E; Watson PH; Murphy LC
J Steroid Biochem Mol Biol; 2008 Mar; 109(1-2):1-10. PubMed ID: 18243688
[TBL] [Abstract][Full Text] [Related]
14. Clinical significance of Stratifin, ERalpha and PR promoter methylation in tumor and serum DNA in Indian breast cancer patients.
Mirza S; Sharma G; Parshad R; Srivastava A; Gupta SD; Ralhan R
Clin Biochem; 2010 Mar; 43(4-5):380-6. PubMed ID: 19961842
[TBL] [Abstract][Full Text] [Related]
15. Estrogen receptor beta--an independent prognostic marker in estrogen receptor alpha and progesterone receptor-positive breast cancer?
Maehle BO; Collett K; Tretli S; Akslen LA; Grotmol T
APMIS; 2009 Sep; 117(9):644-50. PubMed ID: 19703124
[TBL] [Abstract][Full Text] [Related]
16. Impact of estrogen receptor beta on gene networks regulated by estrogen receptor alpha in breast cancer cells.
Chang EC; Frasor J; Komm B; Katzenellenbogen BS
Endocrinology; 2006 Oct; 147(10):4831-42. PubMed ID: 16809442
[TBL] [Abstract][Full Text] [Related]
17. ESR1 gene promoter region methylation in free circulating DNA and its correlation with estrogen receptor protein expression in tumor tissue in breast cancer patients.
Martínez-Galán J; Torres-Torres B; Núñez MI; López-Peñalver J; Del Moral R; Ruiz De Almodóvar JM; Menjón S; Concha A; Chamorro C; Ríos S; Delgado JR
BMC Cancer; 2014 Feb; 14():59. PubMed ID: 24495356
[TBL] [Abstract][Full Text] [Related]
18. A genome-wide study of the repressive effects of estrogen receptor beta on estrogen receptor alpha signaling in breast cancer cells.
Williams C; Edvardsson K; Lewandowski SA; Ström A; Gustafsson JA
Oncogene; 2008 Feb; 27(7):1019-32. PubMed ID: 17700529
[TBL] [Abstract][Full Text] [Related]
19. PES1 promotes breast cancer by differentially regulating ERα and ERβ.
Cheng L; Li J; Han Y; Lin J; Niu C; Zhou Z; Yuan B; Huang K; Li J; Jiang K; Zhang H; Ding L; Xu X; Ye Q
J Clin Invest; 2012 Aug; 122(8):2857-70. PubMed ID: 22820289
[TBL] [Abstract][Full Text] [Related]
20. Expression of estrogen receptor beta in the breast carcinoma of BRCA1 mutation carriers.
Litwiniuk MM; Roznowski K; Filas V; Godlewski DD; Stawicka M; Kaleta R; Breborowicz J
BMC Cancer; 2008 Apr; 8():100. PubMed ID: 18405391
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
